GLP-1 receptor agonists have revolutionized medical weight loss, but they often come with side effects like nausea and appetite suppression, and can lead to nutrient deficiencies
Studies have shown that these drugs can help improve conditions like metabolic dysfunction-associated steatotic liver disease (MASLD), which used to be called non-alcoholic fatty liver disease (NAFLD)
While the dose in a weight loss compound is generally focused on energy and side effects, it highlights the importance of heart health during weight loss
He now specializes in evidence-based weight management, including GLP-1/GIP therapies (semaglutide & tirzepatide)
La popolarit del farmaco non solo tra i pazienti diabetici ma anche tra coloro che cercano soluzioni per la perdita di peso ha messo sotto pressione i fornitori e ha portato a ritardi nella distribuzione e a difficolt nel soddisfare le richieste globali
The first (experimental) problem that has been clearly identified recently is that most of the AD models used in experimental studies are not clinically valid and therefore cannot be adequately translated into the clinic